PATENTSCOPE will be unavailable a few hours for maintenance reason on Monday 03.02.2020 at 10:00 AM CET
Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (WO2004032827) HEPATITIS C VIRUS INHIBITORS
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/2004/032827 International Application No.: PCT/US2003/015856
Publication Date: 22.04.2004 International Filing Date: 20.05.2003
Chapter 2 Demand Filed: 16.12.2003
IPC:
A61K 38/06 (2006.01) ,C07K 5/078 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38
Medicinal preparations containing peptides
04
Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
06
Tripeptides
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
K
PEPTIDES
5
Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof
04
containing only normal peptide links
06
Dipeptides
078
the first amino acid being heterocyclic, e.g. Pro, His, Trp
Applicants:
BRISTOL-MYERS SQUIBB COMPANY [US/US]; P. O. Box 4000 Route 206 and Provinceline Road Princeton, NJ 08543-4000, US (AllExceptUS)
RIPKA, Amy [US/US]; US (UsOnly)
CAMPBELL, Jeffrey, Allen [US/US]; US (UsOnly)
GOOD, Andrew, Charles [US/US]; US (UsOnly)
SCOLA, Paul, Michael [US/US]; US (UsOnly)
SIN, Ny [US/US]; US (UsOnly)
VENABLES, Brian [US/US]; US (UsOnly)
Inventors:
RIPKA, Amy; US
CAMPBELL, Jeffrey, Allen; US
GOOD, Andrew, Charles; US
SCOLA, Paul, Michael; US
SIN, Ny; US
VENABLES, Brian; US
Agent:
VOLLES, Warren, K. ; Bristol-Myers Squibb Company P.O. Box 4000 Princeton, NJ 08543-4000, US
Priority Data:
60/382,15620.05.2002US
Title (EN) HEPATITIS C VIRUS INHIBITORS
(FR) INHIBITEURS DU VIRUS DE L'HEPATITE C
Abstract:
(EN) The present invention relates to tripeptide compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. In particular, the present invention provides novel tripeptide analogs, pharmaceutical compositions containing such analogs and methods for using these analogs in the treatment of HCV infection.
(FR) L'invention concerne des composés tripeptidiques, des compositions et des méthodes de traitement d'infection par le virus de l'hépatite C (HCV). Elle concerne, en particulier, des analogues de tripeptides, des compositions pharmaceutiques contenant de tels analogues et des méthodes d'utilisation de ces analogues dans le traitement d'infection HCV.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NI, NO, NZ, OM, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)
Also published as:
IS7533NO20044897PL373547PLP.373547EP1506172JP2006507264
ES2361011AU2003299519